Bleeding and response to hemostatic therapy in acquired hemophilia A: results from the GTH-AH 01/2010 study

Acquired hemophilia A (AHA) is due to autoantibodies against coagulation factor VIII (FVIII) and most often presents with unexpected bleeding. In contrast to congenital hemophilia, the patient’s residual FVIII activity does not seem to correlate with the risk of bleeding as suggested from previous s...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood
Autori principali: Holstein, Katharina, Liu, Xiaofei, Smith, Andrea, Knöbl, Paul, Klamroth, Robert, Geisen, Ulrich, Eichler, Hermann, Miesbach, Wolfgang, Tiede, Andreas
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2020
Soggetti:
Clinical Trials and Observations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7392842/
https://ncbi.nlm.nih.gov/pubmed/32268359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019003639
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi